Related Experiment Video
Updated: Oct 9, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Targeting the Pathobiology of Diabetic Kidney Disease
1Department of Diabetes, Monash University, Melbourne, Australia.
Abstract:
The pathobiology of diabetic kidney disease (DKD) involves an interplay between all the many different cell types that exist within the kidney and their shared and cumulative dysfunction in response to chronic hyperglycemia. DKD is characteriszed by morphological changes including tubular hypertrophy, podocyte dysfunction, mesangial expansion and mesangiolysis, endothelitis and capillary rarefaction, arteriolar hyalinosis, basement membrane thickening, and ultimately nephron dropout and tubulointerstitial fibrosis. These adaptive but ultimately maladaptive changes accelerate the progression of lesions in the diabetic kidney by increasing mechanical and oxidative stress, hypoxia, fibrogenesis, inflammation, senescence, and apoptosis. In particular, atrophy at the critical junction between Bowman's capsule and the proximal tubule likely represent the leading cause of nephron dropout and kidney function decline in DKD. Preventing, slowing, or reversing these changes should be the target of future "smart" therapies for patients with DKD, many of which are now under development.
Insights
Diabetic kidney disease (DKD) arises from complex cellular dysfunction due to chronic hyperglycemia, leading to kidney damage. Future therapies aim to prevent, slow, or reverse these maladaptive changes for better patient outcomes.
Area of Science:
- Nephrology
- Endocrinology
- Cell Biology
Background:
- Diabetic kidney disease (DKD) is a major complication of diabetes mellitus.
- Chronic hyperglycemia drives complex cellular dysfunction within the kidney.
Purpose of the Study:
- To elucidate the pathobiology of DKD.
- To identify key pathological changes and their contribution to disease progression.
- To highlight therapeutic targets for DKD.
Main Methods:
- Review of existing literature on DKD pathobiology.
- Analysis of cellular and morphological changes in DKD.
- Identification of key molecular and cellular stress pathways involved in DKD progression.
Main Results:
- DKD involves interplay between diverse kidney cell types leading to cumulative dysfunction.
- Characterized by tubular hypertrophy, podocyte dysfunction, mesangial expansion, endothelitis, capillary rarefaction, arteriolar hyalinosis, and basement membrane thickening.
- These changes promote mechanical/oxidative stress, hypoxia, fibrogenesis, inflammation, senescence, and apoptosis, culminating in nephron dropout and tubulointerstitial fibrosis.
Conclusions:
- Atrophy at the Bowman's capsule and proximal tubule junction is a key driver of nephron loss and kidney function decline in DKD.
- Targeting these maladaptive changes is crucial for developing effective "smart" therapies for DKD.
- Numerous therapeutic strategies for DKD are currently under development.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Kidney Transplant I: Introduction

